<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="10" family="Symbol" color="#000000"/>
	<fontspec id="font6" size="9" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font7" size="7" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font8" size="10" family="GillSans" color="#ffffff"/>
	<fontspec id="font9" size="10" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font10" size="10" family="GillSans" color="#000000"/>
	<fontspec id="font11" size="7" family="GillSans" color="#000000"/>
	<fontspec id="font12" size="10" family="GillSans,Italic" color="#000000"/>
<text top="41" left="55" width="82" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title"><i>Medical Immunology</i></text>
<text top="41" left="138" width="28" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="0" tag_type="title"> 2006, </text>
<text top="41" left="165" width="5" height="10" font="font2" id="p1_t3" reading_order_no="2" segment_no="0" tag_type="title"><b>5</b></text>
<text top="41" left="170" width="7" height="10" font="font1" id="p1_t4" reading_order_no="3" segment_no="0" tag_type="title">:1</text>
<text top="41" left="384" width="170" height="10" font="font1" id="p1_t5" reading_order_no="4" segment_no="1" tag_type="text">http://www.medimmunol.com/content/5/1/1</text>
<text top="756" left="503" width="51" height="10" font="font1" id="p1_t6" reading_order_no="82" segment_no="8" tag_type="text">Page 9 of 14</text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t7" reading_order_no="83" segment_no="9" tag_type="text"><i>(page number not for citation purposes)</i></text>
<text top="87" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="5" segment_no="2" tag_type="text">determined by subtle immunodominance patterns influ-</text>
<text top="98" left="55" width="241" height="9" font="font4" id="p1_t9" reading_order_no="6" segment_no="2" tag_type="text">enced by many factors including other HLA molecules</text>
<text top="110" left="55" width="241" height="9" font="font4" id="p1_t10" reading_order_no="7" segment_no="2" tag_type="text">and previous pathogenic encounters [<a href="">34]</a>. To address</text>
<text top="122" left="55" width="241" height="9" font="font4" id="p1_t11" reading_order_no="8" segment_no="2" tag_type="text">these possibilities, we analyzed responses in HIV-1 naive</text>
<text top="134" left="55" width="241" height="9" font="font4" id="p1_t12" reading_order_no="9" segment_no="2" tag_type="text">individuals by priming PBMC of ten donors at high cell</text>
<text top="145" left="55" width="241" height="9" font="font4" id="p1_t13" reading_order_no="10" segment_no="2" tag_type="text">density with HIV-1 peptide-pool pulsed autologous Lang-</text>
<text top="157" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="11" segment_no="2" tag_type="text">erhans-like cells followed by restimulation with peptide</text>
<text top="169" left="55" width="241" height="9" font="font4" id="p1_t15" reading_order_no="12" segment_no="2" tag_type="text">pulsed fresh PBMCs. We tested the resulting HIV-1 pep-</text>
<text top="181" left="55" width="241" height="9" font="font4" id="p1_t16" reading_order_no="13" segment_no="2" tag_type="text">tide pool specific T cell lines by ELISPOT analysis. (Figure</text>
<text top="192" left="55" width="126" height="9" font="font4" id="p1_t17" reading_order_no="14" segment_no="2" tag_type="text"><a href="">1B) A</a>ll donors generated IFN</text>
<text top="190" left="181" width="4" height="13" font="font5" id="p1_t18" reading_order_no="15" segment_no="2" tag_type="text">γ</text>
<text top="192" left="185" width="111" height="9" font="font4" id="p1_t19" reading_order_no="16" segment_no="2" tag_type="text"> with a magnitude signifi-</text>
<text top="204" left="55" width="241" height="9" font="font4" id="p1_t20" reading_order_no="17" segment_no="2" tag_type="text">cantly greater (p &lt; 0.0001) than ELISPOT responses gen-</text>
<text top="216" left="55" width="141" height="9" font="font4" id="p1_t21" reading_order_no="18" segment_no="2" tag_type="text">erated by HIV-1-infected subjects.</text>
<text top="240" left="55" width="234" height="9" font="font6" id="p1_t22" reading_order_no="19" segment_no="4" tag_type="title"><i><b>Characterization of A0201 restricted responses in HIV-1 </b></i></text>
<text top="251" left="55" width="69" height="9" font="font6" id="p1_t23" reading_order_no="20" segment_no="4" tag_type="title"><i><b>naive individuals</b></i></text>
<text top="263" left="55" width="241" height="9" font="font4" id="p1_t24" reading_order_no="21" segment_no="5" tag_type="text">To further evaluate specific T cell responses, we selected</text>
<text top="275" left="55" width="241" height="9" font="font4" id="p1_t25" reading_order_no="22" segment_no="5" tag_type="text">the most common HLA subtype, A0201 for detailed anal-</text>
<text top="286" left="55" width="241" height="9" font="font4" id="p1_t26" reading_order_no="23" segment_no="5" tag_type="text">ysis. Eight HIV-1 peptides with A0201 restriction (Table</text>
<text top="298" left="55" width="241" height="9" font="font4" id="p1_t27" reading_order_no="24" segment_no="5" tag_type="text"><a href="">2) were </a>pulsed individually onto the TAP deficient</text>
<text top="310" left="55" width="241" height="9" font="font4" id="p1_t28" reading_order_no="25" segment_no="5" tag_type="text">A0201+ T2 hybridoma cell line to analyze functional pep-</text>
<text top="322" left="55" width="241" height="9" font="font4" id="p1_t29" reading_order_no="26" segment_no="5" tag_type="text">tide binding. A positive control peptide derived from the</text>
<text top="333" left="55" width="241" height="9" font="font4" id="p1_t30" reading_order_no="27" segment_no="5" tag_type="text">HTLV-TAX protein [(amino acids 11–19. LLFGYPVYV)]</text>
<text top="87" left="313" width="241" height="9" font="font4" id="p1_t31" reading_order_no="28" segment_no="3" tag_type="text">was used to normalize positive peptide binding (value =</text>
<text top="98" left="313" width="241" height="9" font="font4" id="p1_t32" reading_order_no="29" segment_no="3" tag_type="text">1). A predicted A0301 restricted HIV-1 peptide was used</text>
<text top="110" left="313" width="241" height="9" font="font4" id="p1_t33" reading_order_no="30" segment_no="3" tag_type="text">as a negative control (value = 0). Each HIV-1 peptide was</text>
<text top="122" left="313" width="241" height="9" font="font4" id="p1_t34" reading_order_no="31" segment_no="3" tag_type="text">found to bind A0201 as shown by increased A0201 sur-</text>
<text top="134" left="313" width="241" height="9" font="font4" id="p1_t35" reading_order_no="32" segment_no="3" tag_type="text">face expression on peptide-pulsed T2 cells (Figure <a href="">2A</a>).</text>
<text top="145" left="313" width="241" height="9" font="font4" id="p1_t36" reading_order_no="33" segment_no="3" tag_type="text">Subsequently, A0201 restricted HIV-1 peptides were com-</text>
<text top="157" left="313" width="241" height="9" font="font4" id="p1_t37" reading_order_no="34" segment_no="3" tag_type="text">bined in a pool and were used to prime an A0201 donor,</text>
<text top="169" left="313" width="241" height="9" font="font4" id="p1_t38" reading_order_no="35" segment_no="3" tag_type="text">resulting in selective proliferation to the HIV-1 peptide</text>
<text top="181" left="313" width="241" height="9" font="font4" id="p1_t39" reading_order_no="36" segment_no="3" tag_type="text">pool compared to control (Figur<a href="">e 2B</a>). These cells pro-</text>
<text top="192" left="313" width="44" height="9" font="font4" id="p1_t40" reading_order_no="37" segment_no="3" tag_type="text">duced IFN</text>
<text top="190" left="357" width="4" height="13" font="font5" id="p1_t41" reading_order_no="38" segment_no="3" tag_type="text">γ</text>
<text top="192" left="361" width="193" height="9" font="font4" id="p1_t42" reading_order_no="39" segment_no="3" tag_type="text"> upon stimulation with HIV-1 peptide-pulsed</text>
<text top="204" left="313" width="241" height="9" font="font4" id="p1_t43" reading_order_no="40" segment_no="3" tag_type="text">antigen-presenting cells (PBMCs) in ELISPOT assays (Fig-</text>
<text top="216" left="313" width="241" height="9" font="font4" id="p1_t44" reading_order_no="41" segment_no="3" tag_type="text"><a href="">ure 2</a>C). After three rounds of stimulation, 25% of the</text>
<text top="228" left="313" width="111" height="9" font="font4" id="p1_t45" reading_order_no="42" segment_no="3" tag_type="text">cells in culture were CD8</text>
<text top="227" left="424" width="6" height="6" font="font7" id="p1_t46" reading_order_no="43" segment_no="3" tag_type="text">+ </text>
<text top="228" left="431" width="87" height="9" font="font4" id="p1_t47" reading_order_no="44" segment_no="3" tag_type="text">and 62% were CD4</text>
<text top="227" left="518" width="6" height="6" font="font7" id="p1_t48" reading_order_no="45" segment_no="3" tag_type="text">+ </text>
<text top="228" left="524" width="30" height="9" font="font4" id="p1_t49" reading_order_no="46" segment_no="3" tag_type="text">(Figure</text>
<text top="239" left="313" width="241" height="9" font="font4" id="p1_t50" reading_order_no="47" segment_no="3" tag_type="text"><a href="">2D). Given</a> that ~20–30% of MHCI binding peptides are</text>
<text top="251" left="313" width="241" height="9" font="font4" id="p1_t51" reading_order_no="48" segment_no="3" tag_type="text">predicted to bind to MHCII as well, this result is not unex-</text>
<text top="263" left="313" width="241" height="9" font="font4" id="p1_t52" reading_order_no="49" segment_no="3" tag_type="text">pected (data not shown). We also generated two control</text>
<text top="275" left="313" width="241" height="9" font="font4" id="p1_t53" reading_order_no="50" segment_no="3" tag_type="text">cell lines: the first, a tetanus toxoid specific T cell line with</text>
<text top="286" left="313" width="42" height="9" font="font4" id="p1_t54" reading_order_no="51" segment_no="3" tag_type="text">78% CD4</text>
<text top="286" left="355" width="6" height="6" font="font7" id="p1_t55" reading_order_no="52" segment_no="3" tag_type="text">+ </text>
<text top="286" left="361" width="53" height="9" font="font4" id="p1_t56" reading_order_no="53" segment_no="3" tag_type="text">and no CD8</text>
<text top="286" left="413" width="6" height="6" font="font7" id="p1_t57" reading_order_no="54" segment_no="3" tag_type="text">+ </text>
<text top="286" left="419" width="135" height="9" font="font4" id="p1_t58" reading_order_no="55" segment_no="3" tag_type="text">T cells elicited by whole protein</text>
<text top="298" left="313" width="241" height="9" font="font4" id="p1_t59" reading_order_no="56" segment_no="3" tag_type="text">stimulation; and the second, an EBV specific T cell line</text>
<text top="310" left="313" width="64" height="9" font="font4" id="p1_t60" reading_order_no="57" segment_no="3" tag_type="text">with 62% CD8</text>
<text top="309" left="377" width="6" height="6" font="font7" id="p1_t61" reading_order_no="58" segment_no="3" tag_type="text">+ </text>
<text top="310" left="384" width="62" height="9" font="font4" id="p1_t62" reading_order_no="59" segment_no="3" tag_type="text">and 29% CD4</text>
<text top="309" left="445" width="6" height="6" font="font7" id="p1_t63" reading_order_no="60" segment_no="3" tag_type="text">+ </text>
<text top="310" left="451" width="103" height="9" font="font4" id="p1_t64" reading_order_no="61" segment_no="3" tag_type="text">cells elicited by stimula-</text>
<text top="322" left="313" width="241" height="9" font="font4" id="p1_t65" reading_order_no="62" segment_no="3" tag_type="text">tion with an immunodominant EBV epitope BMLF1</text>
<text top="333" left="313" width="88" height="9" font="font4" id="p1_t66" reading_order_no="63" segment_no="3" tag_type="text">(GLCTLVAML). CD8</text>
<text top="333" left="401" width="6" height="6" font="font7" id="p1_t67" reading_order_no="64" segment_no="3" tag_type="text">+ </text>
<text top="333" left="407" width="147" height="9" font="font4" id="p1_t68" reading_order_no="65" segment_no="3" tag_type="text">T cells were sorted from the HIV-1</text>
<text top="604" left="55" width="473" height="9" font="font8" id="p1_t69" reading_order_no="67" segment_no="6" tag_type="title">Generation and characterization of HLA-A0201 restricted HIV-1 peptide-specific T cell lines from uninfected individuals</text>
<text top="604" left="55" width="37" height="9" font="font9" id="p1_t70" reading_order_no="66" segment_no="6" tag_type="title"><b>Figure 2</b></text>
<text top="615" left="55" width="497" height="9" font="font9" id="p1_t71" reading_order_no="68" segment_no="7" tag_type="text"><b>Generation and characterization of HLA-A0201 restricted HIV-1 peptide-specific T cell lines from uninfected </b></text>
<text top="626" left="55" width="48" height="9" font="font9" id="p1_t72" reading_order_no="69" segment_no="7" tag_type="text"><b>individuals</b></text>
<text top="626" left="103" width="451" height="9" font="font10" id="p1_t73" reading_order_no="70" segment_no="7" tag_type="text">. Binding of HIV-1 peptides to A0201 was tested using the T2 cell line (panel A). These HIV-1 peptide-stimulated T </text>
<text top="637" left="55" width="495" height="9" font="font10" id="p1_t74" reading_order_no="71" segment_no="7" tag_type="text">cells generated antigen-specific proliferative responses (panel B). ELISPOT responses to HIV-1 peptide-loaded donor PBMCs </text>
<text top="647" left="55" width="496" height="9" font="font10" id="p1_t75" reading_order_no="72" segment_no="7" tag_type="text">or PHA stimulation (positive control) as well as to non-peptide loaded donor PBMCs (negative control) (Panel C). Flow cyto-</text>
<text top="658" left="55" width="493" height="9" font="font10" id="p1_t76" reading_order_no="73" segment_no="7" tag_type="text">metric analysis of CD4 and CD8 T cells in HIV-1 peptide-specific T cell lines and indicated control T cell lines (Panel D). CD8</text>
<text top="658" left="548" width="6" height="6" font="font11" id="p1_t77" reading_order_no="74" segment_no="7" tag_type="text">+ </text>
<text top="669" left="55" width="321" height="9" font="font10" id="p1_t78" reading_order_no="75" segment_no="7" tag_type="text">T cells were sorted from the HIV-1 specific T cell line after multiple stimulations </text>
<text top="669" left="376" width="27" height="9" font="font12" id="p1_t79" reading_order_no="76" segment_no="7" tag_type="text"><i>in vitro </i></text>
<text top="669" left="403" width="142" height="9" font="font10" id="p1_t80" reading_order_no="77" segment_no="7" tag_type="text">and their peptide specificities deter-</text>
<text top="680" left="55" width="499" height="9" font="font10" id="p1_t81" reading_order_no="78" segment_no="7" tag_type="text">mined by individual peptide-loaded DimerX staining (Panel E). In Panel E, the negative control straining was obtained using the </text>
<text top="690" left="55" width="479" height="9" font="font10" id="p1_t82" reading_order_no="79" segment_no="7" tag_type="text">HIV-1 specific T cell line and a non-relevant peptide loaded DimerX. The EBV positive control was obtained using donor </text>
<text top="701" left="55" width="495" height="9" font="font10" id="p1_t83" reading_order_no="80" segment_no="7" tag_type="text">PBMC's stimulated with 1uM BMLF-1 EBV peptide for one week and then stained with EBV peptide loaded Dimer X. One to </text>
<text top="712" left="55" width="385" height="9" font="font10" id="p1_t84" reading_order_no="81" segment_no="7" tag_type="text">nine percent of CD8 T cells were specific for each one of the selected HIV-1B peptides (Panel F).</text>
</page>
</pdf2xml>
